UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches

Journal of pharmaceutical and biomedical analysis, 2018-04, Vol.152, p.204-214

2018

Volltextzugriff (PDF)

Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases

Clinical chemistry and laboratory medicine, 2017-08, Vol.55 (9), p.1324

2017

Volltextzugriff (PDF)

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients

PloS one, 2013-03, Vol.8 (3), p.e60239-e60239

2013

Volltextzugriff (PDF)

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

British journal of pharmacology, 2010-06, Vol.160 (4), p.919-930

2010

Volltextzugriff (PDF)

Oxycodone concentrations in the central nervous system and cerebrospinal fluid after epidural administration to the pregnant ewe

Basic & clinical pharmacology & toxicology, 2019-11, Vol.125 (5), p.430-438

2019

Volltextzugriff (PDF)

Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016-01, Vol.1008, p.174-180

2016

Volltextzugriff (PDF)

Case Report of Methylone, Oxymorphone and Ethanol in a Fatality Case with Tissue Distribution

Journal of analytical toxicology, 2016-09, Vol.40 (7), p.543-545

2016

Volltextzugriff (PDF)

A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system

Pain management, 2017-11, Vol.7 (6), p.499-512

2017

Volltextzugriff (PDF)

The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets

The journal of pain, 2012, Vol.13 (1), p.90-99

2012

Volltextzugriff (PDF)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients

European journal of clinical pharmacology, 2011-05, Vol.67 (5), p.493-506

2011

Volltextzugriff (PDF)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

European journal of clinical pharmacology, 2012-01, Vol.68 (1), p.55-64

2012

Volltextzugriff (PDF)

Cancer Cachexia Raises the Plasma Concentration of Oxymorphone Through the Reduction of CYP3A But Not CYP2D6 in Oxycodone-Treated Patients

Journal of clinical pharmacology, 2013-08, Vol.53 (8), p.812-818

2013

Volltextzugriff (PDF)

Simultaneous determination of oxymorphone and its active metabolite 6-OH-oxymorphone in human plasma by high performance liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012-08, Vol.902, p.116-121

2012

Volltextzugriff (PDF)

Multi-drug and Metabolite Quantification in Postmortem Blood by Liquid Chromatography–High-Resolution Mass Spectrometry: Comparison with Nominal Mass Technology

Journal of analytical toxicology, 2014-10, Vol.38 (8), p.495-506

2014

Volltextzugriff (PDF)

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia

Acta anaesthesiologica Scandinavica, 2010-02, Vol.54 (2), p.232-240

2010

Volltextzugriff (PDF)

Pharmacokinetics of ammonium sulfate gradient loaded liposome–encapsulated oxymorphone and hydromorphone in healthy dogs

Veterinary anaesthesia and analgesia, 2013-09, Vol.40 (5), p.537-545

2013

Volltextzugriff (PDF)

Determination of Oxycodone, Noroxycodone and Oxymorphone by High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry in Human Matrices: In vivo and In vitro Applications

Journal of analytical toxicology, 2013-07, Vol.37 (6), p.337-344

2013

Volltextzugriff (PDF)

Pharmacokinetics and Dose-Proportionality of Oxymorphone Extended Release and Its Metabolites: Results of a Randomized Crossover Study

Pharmacotherapy, 2004-04, Vol.24 (4), p.468-476

2004

Volltextzugriff (PDF)

SEX DIFFERENCES IN THE PHARMACOKINETICS, OXIDATIVE METABOLISM AND ORAL BIOAVAILABILITY OF OXYCODONE IN THE SPRAGUE-DAWLEY RAT

Clinical and experimental pharmacology & physiology, 2008-03, Vol.35 (3), p.295-302

2008

Volltextzugriff (PDF)

Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients

PloS one, 2014-08, Vol.9 (8), p.e104215

2014

Volltextzugriff (PDF)

Validation of blood and liver oxymorphone analysis using LC-MS-MS: concentrations in 30 fatal overdoses

Journal of analytical toxicology, 2013-10, Vol.37 (8), p.512-516

2013

Volltextzugriff (PDF)

Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End‐Stage Renal Disease

Pain practice, 2017-06, Vol.17 (5), p.604-615

2017

Volltextzugriff (PDF)

CYP3A53 Affects Plasma Disposition of Noroxycodone and Dose Escalation in Cancer Patients Receiving Oxycodone

Journal of clinical pharmacology, 2011-11, Vol.51 (11), p.1529-1538

2011

Volltextzugriff (PDF)

Case Management in a DUI Lab: Effect on Drugs Reported

Journal of analytical toxicology, 2014-10, Vol.38 (8), p.555-558

2014

Volltextzugriff (PDF)

Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-04, Vol.848 (2), p.264-270

2007

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(116)
Buchkapitel
(1)

Sprache

Englisch
(117)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(95)
Male
(72)
Animals
(60)
Humans
(55)
Female
(53)
Oxymorphone - Blood
(49)
Oxymorphone - Pharmacology
(42)
Analgesics, Opioid - Blood
(34)
Pharmacology & Pharmacy
(34)
Biological And Medical Sciences
(32)
Oxycodone - Blood
(29)
Oxymorphone - Administration & Dosage
(29)
Medical Sciences
(28)
Veterinary Sciences
(28)
Adult
(26)
Oxymorphone
(26)
Analgesics, Opioid - Administration & Dosage
(24)
Analgesics, Opioid - Pharmacokinetics
(24)
Blood Pressure - Drug Effects
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches

Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Oxycodone concentrations in the central nervous system and cerebrospinal fluid after epidural administration to the pregnant ewe

Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography–tandem mass spectrometry

Case Report of Methylone, Oxymorphone and Ethanol in a Fatality Case with Tissue Distribution

A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system

The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

Cancer Cachexia Raises the Plasma Concentration of Oxymorphone Through the Reduction of CYP3A But Not CYP2D6 in Oxycodone-Treated Patients

Simultaneous determination of oxymorphone and its active metabolite 6-OH-oxymorphone in human plasma by high performance liquid chromatography–tandem mass spectrometry

Multi-drug and Metabolite Quantification in Postmortem Blood by Liquid Chromatography–High-Resolution Mass Spectrometry: Comparison with Nominal Mass Technology

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia

Pharmacokinetics of ammonium sulfate gradient loaded liposome–encapsulated oxymorphone and hydromorphone in healthy dogs

Determination of Oxycodone, Noroxycodone and Oxymorphone by High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry in Human Matrices: In vivo and In vitro Applications

Pharmacokinetics and Dose-Proportionality of Oxymorphone Extended Release and Its Metabolites: Results of a Randomized Crossover Study

SEX DIFFERENCES IN THE PHARMACOKINETICS, OXIDATIVE METABOLISM AND ORAL BIOAVAILABILITY OF OXYCODONE IN THE SPRAGUE-DAWLEY RAT

Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients

Validation of blood and liver oxymorphone analysis using LC-MS-MS: concentrations in 30 fatal overdoses

Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End‐Stage Renal Disease

CYP3A53 Affects Plasma Disposition of Noroxycodone and Dose Escalation in Cancer Patients Receiving Oxycodone

Case Management in a DUI Lab: Effect on Drugs Reported

Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry

Suchergebnisse filtern